First ‘gene silencing’ drug for Alzheimer’s disease shows promise
24 April 2023
A world-first trial at 911±¬ÁÏÍø and UCLH led by Dr Catherine Mummery (UCL Queen Square Institute of Neurology)Ìýhas found a new genetic therapy for Alzheimer’s disease that is able to safely and successfully lower levels of the harmful tau protein known to cause the disease.
Close
